Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.32 |
| ▸ | CCR5 | P51681 | 2/20 | 0.32 |
| ▸ | CCR8 | P51685 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16919836 | 0.78 | CCR1 (0.36) | CCR1CCR5CCR8RAB9AMEN1 | |
| SCHEMBL4406428 | 0.70 | KDM4E (0.30) | — | |
| SCHEMBL26194074 | 0.69 | MAPT (0.33) | MEN1MAPTKMT2A | |
| SCHEMBL23482399 | 0.67 | MEN1 (0.32) | MEN1MAPTKMT2A | |
| SCHEMBL24484220 | 0.66 | MAPT (0.32) | MEN1MAPTKMT2A | |
| SCHEMBL21560873 | 0.66 | MAPK1 (0.40) | RAB9AMEN1KMT2ACYP2A6 | |
| SCHEMBL24121913 | 0.65 | KDM4E (0.34) | CCR1CCR5CCR8 | |
| SCHEMBL24122030 | 0.65 | CHRM4 (0.31) | CCR1CCR5CCR8 | |
| SCHEMBL22224011 | 0.65 | CCR1 (0.30) | CCR1CCR5RAB9A | |
| SCHEMBL7454028 | 0.64 | NR4A2 (0.39) | CCR1CCR5CCR8RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11647671-B2 | Compound and organic electro-optical device containing the same | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11647671-B2 | Compound and organic electro-optical device containing the same | EPCAM, LPO, CYBA | CCR1 4540/4885CCR5 4531/4885CCR8 4292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.